Search clinical trials for: RG1662

Total 26 results

Hoffmann-La Roche

Completed

Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662

Healthy Volunteer

United Kingdom
Hoffmann-La Roche

Completed

A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers

Healthy Volunteer

Netherlands
Hoffmann-La Roche

Completed

A Study of RG1662 in Individuals With Down Syndrome

Down Syndrome

United States, United Kingdom
Hoffmann-La Roche

Completed

A Molecular and Functional Brain Imaging Study in Individuals With Down Syndrome and Healthy Controls Following Single Dose RG1662

Healthy Volunteer, Down Syndrome

United Kingdom
Hoffmann-La Roche

Completed

A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)

Down Syndrome

United States, Italy, Argentina, France, Spain, Mexico, Canada, New Zealand, Singapore, United Kingdom
Hoffmann-La Roche

Completed

Basmisanil Positron Emission Tomography Study in Japanese Volunteers

Healthy Volunteer

United Kingdom
Respivert Ltd

Completed

Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients

Healthy Volunteers | Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Hoffmann-La Roche

Completed

A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.

Asthma

United States
Genentech, Inc.

Completed

A Study of RG7667 in Healthy Volunteers

Healthy Volunteer

United States
Hoffmann-La Roche

Completed

A Study of the Effect of RG1662 on Metformin in Healthy Volunteers

Healthy Volunteer

United Kingdom
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Neuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)

United States, Korea, Republic of, Malaysia, Turkey, Bulgaria, Canada, Poland, Puerto Rico, Romania, Croatia, Georgia, Italy, Philippines, Taiwan, Ukraine
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

Neuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)

Spain, Italy, United States, Japan, Poland, Taiwan, Germany, United Kingdom, Hungary, France, Ukraine
Hoffmann-La Roche

Completed

A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects

Healthy Patient Study

United Kingdom
Columbia University

Withdrawn

Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency

Pancreatic Cancer
Elizabeth Hecht

Withdrawn

Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection

Pancreatic Cancer | Intraductal Papillary Mucinous Neoplasm
Massachusetts General Hospital

Terminated

Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic Pancreatitis

Chronic Pancreatitis

United States
Massachusetts General Hospital

Terminated

Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas

Intraductal Papillary Mucinous Neoplasms

United States
Columbia University

Withdrawn

Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery

Pancreatic Cancer

United States
Indiana University School of Medicine
Repligen Corporation; Shekhar, Anantha M.D., Ph.D.

Completed

Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder

Obsessive Compulsive Disorder (OCD)

United States
University Hospitals Cleveland Medical Center
Repligen Corporation

Withdrawn

Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity

Pancreas Cancer

United States
Massachusetts General Hospital

Terminated

Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population

Chronic Pancreatitis | Acute Recurrent Pancreatitis

United States
Repligen Corporation

Completed

Synthetic Human Secretin in Children With Autism

Autism

United States
Repligen Corporation

Completed

Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas

Pancreatitis
Repligen Corporation

Terminated

Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction

Autism
Elizabeth Hecht

Completed

Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients

Pancreatic Cancer

United States
Copenhagen Studies on Asthma in Childhood

Active, not recruiting

Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood

Asthma | Allergy | Eczema

Denmark

3

Subscribe